Asset Details
Do you wish to reserve the book?
Successful Implementation of a Shared Medical Appointment Model for Hepatitis C Treatment at a Community Health Center
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Successful Implementation of a Shared Medical Appointment Model for Hepatitis C Treatment at a Community Health Center
Do you wish to request the book?
Successful Implementation of a Shared Medical Appointment Model for Hepatitis C Treatment at a Community Health Center
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Successful Implementation of a Shared Medical Appointment Model for Hepatitis C Treatment at a Community Health Center
2019
Overview
Highly efficacious direct acting antiviral (DAA) therapy for treatment of Hepatitis C Virus (HCV) infection is largely inaccessible to communities facing a shortage of available specialist providers. Though less demanding than previous interferon regimens, DAA therapy requires patients to adhere to 8–12 weeks of daily treatment, which can be challenging for some patient populations. Duffy Health Center, located on Cape Cod, Massachusetts, provides integrated medical, mental health and case management services to people who are homeless or at risk for homelessness. The goal of this manuscript is to evaluate the outcomes of treatment of HCV infection with a shared medical appointment (SMA) model. The primary outcome was sustained virologic response (SVR-12), or HCV RNA ≤ 15 IU/mL at 12 weeks post-treatment. There were 102 patients recruited, with a total of 104 treatments administered. Over three-fourths of patients who attended one SMA visit (78 of 102) continued in SMA for the duration of treatment. Of these patients opting for SMA, 99% (77 of 78) completed the full treatment course, and 91% (71 of 78) of SMA patients achieved SVR-12. DAA therapy provided by non-specialist providers using the SMA model yielded comparable response rates to those achieved by specialist providers, and has the potential to substantially increase access to HCV treatment for patient populations within high-risk communities.
Publisher
Springer Science + Business Media,Springer US,Springer Nature B.V
Subject
/ Antiviral Agents - therapeutic use
/ Community and Environmental Psychology
/ Community Health Centers - organization & administration
/ Continuity of Patient Care - standards
/ Ethics
/ Female
/ Health Promotion and Disease Prevention
/ Hepatitis C, Chronic - drug therapy
/ Humans
/ Male
/ Medicine
/ Patients
/ RNA
/ Shared Medical Appointments - organization & administration
/ Sustained Virologic Response
/ Therapy
/ Viruses
